Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial.
Montfort A, Filleron T, Virazels M, Dufau C, Milhès J, Pagès C, Olivier P, Ayyoub M, Mounier M, Lusque A, Brayer S, Delord JP, Andrieu-Abadie N, Levade T, Colacios C, Ségui B, Meyer N. Montfort A, et al. Among authors: pages c. Clin Cancer Res. 2021 Feb 15;27(4):1037-1047. doi: 10.1158/1078-0432.CCR-20-3449. Epub 2020 Dec 3. Clin Cancer Res. 2021. PMID: 33272982 Clinical Trial.
Multiple Keratoacanthoma-like Lesions in a Patient Treated with Pembrolizumab.
Fradet M, Sibaud V, Tournier E, Lamant L, Boulinguez S, Brun A, Pages C, Meyer N. Fradet M, et al. Among authors: pages c. Acta Derm Venereol. 2019 Dec 1;99(13):1301-1302. doi: 10.2340/00015555-3301. Acta Derm Venereol. 2019. PMID: 31449315 Free article. No abstract available.
Sample CME manuscript submission: Response to the article by Pham et al entitled "Review BRAF inhibition and the spectrum of granulomatous reactions".
Marcaillou M, Dion J, Baroudjian B, Ezrine E, Carrera C, Anderle A, Apalla Z, Freites-Martinez A, Pages C, Lebbe C, Meyer N, Sibaud V, Comont T. Marcaillou M, et al. Among authors: pages c. J Am Acad Dermatol. 2022 Aug;87(2):e85-e88. doi: 10.1016/j.jaad.2022.04.053. Epub 2022 May 5. J Am Acad Dermatol. 2022. PMID: 35526651 No abstract available.
Single-center study under a French Temporary Authorization for Use (TAU) protocol for ipilimumab in metastatic melanoma: negative impact of baseline corticosteroids.
Chasset F, Pages C, Biard L, Roux J, Sidina I, Madelaine I, Basset-Seguin N, Viguier M, Madjlessi-EzrA N, Schneider P, Bagot M, Resche-Rigon M, Lebbe C. Chasset F, et al. Among authors: pages c. Eur J Dermatol. 2015 Jan-Feb;25(1):36-44. doi: 10.1684/ejd.2014.2471. Eur J Dermatol. 2015. PMID: 25500362
168 results